Perspectives on the Treatment of Malignant Pleural Mesothelioma von Janes, Sam M, Alrifai, Doraid, Fennell, Dean A

Volltext

Beyond chemoradiotherapy: improving treatment outcomes for patients with stage III unresectable non-small-cell lung cancer through immuno-oncology and durvalumab (Imfinzi®▼, AstraZ... von Patel, Priyanka, Alrifai, Doraid, McDonald, Fiona, Forster, Martin

Volltext

Beyond chemoradiotherapy: improving treatment outcomes or patients with stage III nresectable non-small-cell lung cancer through immuno-oncology and durvalumab (Imfinzi (R) Down-po... von Patel, Priyanka, Alrifai, Doraid, McDonald, Fiona, Forster, Martin

Volltext

Palliative care in mesothelioma: Are current services RESPECT-able enough? von Kumar, Neelam, Alrifai, Doraid, Psallidas, Ioannis

Volltext

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients von Abdul-Jawad, Sultan, Baù, Luca, Alaguthurai, Thanussuyah, del Molino del Barrio, Irene, Laing, Adam G., Hayday, Thomas S., Monin, Leticia, Muñoz-Ruiz, Miguel, McDonald, Louisa, Francos Quijorna, Isaac, McKenzie, Duncan, Davis, Richard, Lorenc, Anna, Chan, Julie Nuo En, Ryan, Sarah, Bugallo-Blanco, Eva, Yorke, Rozalyn, Kamdar, Shraddha, Fish, Matthew, Zlatareva, Iva, Vantourout, Pierre, Jennings, Aislinn, Gee, Sarah, Doores, Katie, Bailey, Katharine, Hazell, Sophie, De Naurois, Julien, Moss, Charlotte, Russell, Beth, Khan, Aadil A., Rowley, Mark, Benjamin, Reuben, Enting, Deborah, Alrifai, Doraid, Wu, Yin, Zhou, You, Barber, Paul, Ng, Tony, Spicer, James, Van Hemelrijck, Mieke, Kumar, Mayur, Vidler, Jennifer, Lwin, Yadanar, Fields, Paul, Karagiannis, Sophia N., Coolen, Anthony C.C., Rigg, Anne, Papa, Sophie, Hayday, Adrian C., Patten, Piers E.M., Irshad, Sheeba

Volltext

Enhancing the effect of Tumour necrosis factor - Related Apoptosis Inducing Ligand (TRAIL) in malignant pleural mesothelioma von Alrifai, Doraid

Volltext bestellen

BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma von Ishii, Yuki, Kolluri, Krishna K., Pennycuick, Adam, Zhang, Xidan, Nigro, Ersilia, Alrifai, Doraid, Borg, Elaine, Falzon, Mary, Shah, Khalid, Kumar, Neelam, Janes, Sam M.

Volltext

Second-line chemotherapy for locally advanced or metastatic small cell lung cancer von Draper, Adrian, Ong, Yee-Ean, Milan, Stephen J, Powell, Steve, McGrath, Sophie, Benepal, Tim, Alrifai, Doraid

Volltext

Evaluation of CA 19-9, a predictive biomarker of response and survival in patients undergoing chemotherapy for metastatic pancreatic ductal adenocarcinoma von Alrifai, Doraid, Germanou, Styliani, Sarker, Debashis, Ross, Paul J., Young, Anna-Mary, Chow, Jason

Volltext

Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours von Childs, Alexa, Kirkwood, Amy, Edeline, Julien, Luong, Tu Vinh, Watkins, Jennifer, Lamarca, Angela, Alrifai, Doraid, Nsiah-Sarbeng, Phyllis, Gillmore, Roopinder, Mayer, Astrid, Thirlwell, Christina, Sarker, Debashis, Valle, Juan W, Meyer, Tim

Volltext

TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma von Davies, Alice, Sage, Beth, Kolluri, Krishna, Alrifai, Doraid, Graham, Rebecca, Weil, Ben, Rego, Rita, Bain, Owen, Patrick, P. Stephen, Champion, Kim, Day, Alex, Popova, Bilyana, Wheeler, Graham, Fullen, Dan, Kalbur, Tammy, Forster, Martin, Lowdell, Mark, Janes, Sam

Volltext

Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma von Kumar, Neelam, Alrifai, Doraid, Kolluri, Krishna K., Sage, Elizabeth K., Ishii, Yuki, Guppy, Naomi, Borg, Elaine, Falzon, Mary, Nankivell, Matthew, Nicholson, Andrew G., Janes, Sam M.

Volltext

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells von Kolluri, Krishna Kalyan, Alifrangis, Constantine, Kumar, Neelam, Ishii, Yuki, Price, Stacey, Michaut, Magali, Williams, Steven, Barthorpe, Syd, Lightfoot, Howard, Busacca, Sara, Sharkey, Annabel, Yuan, Zhenqiang, Sage, Elizabeth K, Vallath, Sabarinath, Le Quesne, John, Tice, David A, Alrifai, Doraid, von Karstedt, Sylvia, Montinaro, Antonella, Guppy, Naomi, Waller, David A, Nakas, Apostolos, Good, Robert, Holmes, Alan, Walczak, Henning, Fennell, Dean A, Garnett, Mathew, Iorio, Francesco, Wessels, Lodewyk, McDermott, Ultan, Janes, Samuel M

Volltext

A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations von Alrifai, Doraid, Popat, Sanjay, Ahmed, Merina, Gonzalez, David, Nicholson, Andrew G, Parcq, John du, Benepal, Tim

Volltext

Emerging resistance pathways in lung cancer: what has ROS-1 taught us? von Alrifai, Doraid, Forster, Martin D., Janes, Sam M.

Volltext